Hi [[ session.user.profile.firstName ]]

OCT: Does It Have What It Takes?

Following a concise and general overview of OCT technology and its clinical applications, this briefing will examine the feasibility of OCT as a viable alternative to existing medical practices and discuss key influential growth factors determining the OCT market’s ability to reach performance targets anticipated by published market projections.
Recorded Sep 14 2010 49 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Roberto G. Aranibar, Frost & Sullivan Research Analyst
Presentation preview: OCT: Does It Have What It Takes?

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • Everything You Need to Know About Critical Healthcare Segments Feb 27 2018 6:30 am UTC 120 mins
    Sanjeev Kumar (Industry Manager), Natasha Gulati (Industry Manager), Siddharth Shah (Industry Analyst)
    Frost & Sullivan is forecasting another year of disruptions in critical healthcare segments such as diabetes care, smart hospitals, healthcare cloud computing and digital pathology. This webinar will focus on these industries along with insights on key trends influencing the healthcare system, followed by a live question-and-answer session.

    Join Us to Gain Insights on:

    • Future paradigms in diabetes care and harnessing evolutionary trends to improve the quality of life for diabetics
    • Understanding the smart hospital concept and identifying relevant applications and growth opportunities
    • Healthcare cloud computing trends, such as global provider spending on cloud solutions approaching $10 billion by 2021
    • Growth opportunities in the global digital pathology market
  • 2018 Frost & Sullivan Predictions and Outlook for Digital Health Feb 22 2018 4:00 pm UTC 60 mins
    Daniel Ruppar, Global Program Director, Analysts from Frost & Sullivan's Global Digital Health Team
    Expert Insights You Will Not Want to Miss:

    • Hear market predictions from world-renowned analysts
    • Learn areas of growth and controversy for 2018 in digital health and health IT
    • Discussions on hot areas including AI, Digital Therapeutics and Blockchain
    • Movements of major ICT and Technology companies in their Healthcare strategy
    • Understand the critical vendors to watch for this year
  • The Picture Perfect Future of the US Medical Imaging Industry Recorded: Jan 23 2018 62 mins
    Frost & Sullivan Transformational Health Team, Shannon Werb, vRad
    The US medical imaging industry is transforming to cope with the challenges of the present and the demands of the future. The current care provision landscape is highly fragmented, and a coherent strategy is required to enhance interoperability among stakeholders across the imaging ecosystem. Stakeholders across the industry must also come together to eliminate redundancies and duplications, and streamline the imaging process, to improve the patient experience.
  • 2018 Global Healthcare Market Predictions Revealed Recorded: Dec 13 2017 60 mins
    Reenita Das, Partner, Kamaljit Behera, Industry Analyst, Neil Jordan, Microsoft, Kay Eron, Intel, Keith Bigelow,GE Healthcare
    2018 will be a tipping point for mainstream adoption of popular digital health technology solutions such as artificial intelligence, mHealth/wearables, telehealth, Big Data analytics, and robotics. The transition of technologies from ideation to actionable applications will drive new opportunities across the globe.

    From data monetization unleashing the power of patient data to digital transformation of patient monitoring, there will be growing awareness of current inefficiencies and new opportunities identified to improve the efficiency of healthcare delivery.
  • R&D Investments and Digitization Propel Growth of Diagnostic Solutions in Asia Recorded: Dec 6 2017 58 mins
    Rhenu Bhuller, Partner & Sanjeev Kumar, Industry Manager (Frost & Sullivan), Dr. Allen Lai, SVP of ACT Genomics Singapore
    The industry is being disrupted by integration of the multi-disciplinary capabilities in biology, chemistry and computational power that companies can leverage to develop new solutions to diagnose, treat and manage chronic disease conditions, such as cancer, cardiovascular disease and diabetes. There is immense pressure on companies to build competencies in product development, manufacturing and distribution of new technology platforms such as point-of-care molecular diagnostics to capture new growth opportunities in the precision medicine market—a paradigm shift that will transform clinical practice and treatment outcomes.
  • Healthcare's Challenges with Blockchain - A Promising but Bumpy Ride! Recorded: Oct 3 2017 57 mins
    Reenita Das, Partner, Kamaljit Behera, Frost & Sullivan, IOTA Foundation, Hashed Health, Healthchain
    We invite you to join Frost & Sullivan’s Transformational Healthcare team and industry experts to discuss blockchain technology with the most potential applications across the healthcare industry, including data interoperability, cybersecurity, insurance fraud management, and drug supply chain provenance. Learn how to differentiate the hype from reality and hear key strategic considerations for future success.
  • Digital Health Markets Update: From AI to Zzzs - What Comes Next? Recorded: Aug 29 2017 53 mins
    Daniel Ruppar, Global Program Director - Digital Health
    Digital health brings a diverse range of growth opportunities for vendors across the value chain. As the space evolves we have experienced a multitude of stepwise successes and stellar failures, yet funding continues to flood the sector. Major moves continue to come into the industry from the broader vendor environment, underlining the importance of health in everyone’s lives and progressively in strategic interests of the C-Suite across the ecosystem. Join Frost & Sullivan in this webinar update showcasing different facets of the market, and learn why there’s something for everyone in digital health.
  • NGS: New Business Models in Diagnostics and Drug Development Recorded: Aug 9 2017 58 mins
    Frost & Sullivan Transformational Health Team, Dr. Misha Kapushesky,Genestack CEO and Dr. Elia Stupka,Boehringer Ingelheim
    Next-generation sequencing (NGS) has emerged as a key technology to deliver the next level of healthcare solutions. While the $1,000 genome was achieved in 2015, Frost & Sullivan predicts the $100 genome to be possible by 2024. The significant dip in cost of extracting genetic data has led to the creation of massive genomic data volumes that are expected to be some of the largest data sets globally by 2025, exceeding data generated by YouTube and Twitter.
  • Beyond Superior Care Quality—How Can APAC Hospitals Become Truly Patient Centric Recorded: Jul 26 2017 61 mins
    Frost & Sullivan, Gabe Rjipma,Microsoft, Dr. Timothy Low, Farrer Park Hospital, David Vu, GE Healthcare Asia-Pacific
    Hospital information technology (Hospital IT) spending in Asia-Pacific (APAC) will grow at a compound annual growth rate of 9.7% between 2016 and 2021 to reach an estimated end-stage market size of more than $15 billion. Key growth opportunities in the region include solutions for Healthcare Data Continuity, Patient Engagement & Experience, Healthcare Cloud, Big Data & Analytics, and Healthcare Cybersecurity. However, the identification of these growth opportunities is only the first step toward succeeding as an ICT vendor in this market. The real demystification lies in understanding very specific target customer needs and then building a value proposition and business model that addresses those needs.
  • 2017 Frost & Sullivan Predictions in Diagnostics Recorded: Mar 23 2017 64 mins
    Transformational Health Team, Harry Glorikian, Board Advisor and Eunice Teo, Director, Business Development, QuantuMDx
    The global clinical diagnostics industry is undergoing a transformation propelled by laboratory consolidation and automation, an enormous move toward data-driven healthcare, large investments in unifying technologies, and renewed business models driven by products and value-added services. There is immense pressure on companies to radically improve new product innovation, manufacturing, and distribution of technologies such as point-of-care molecular diagnostics to capture new growth opportunities in the precision medicine market.
  • 2017 Frost & Sullivan Predictions in Digital Health Recorded: Jan 31 2017 59 mins
    Digital Health Team: Daniel Ruppar, Nancy Fabozzi and Victor Camlek
    Over the past decade, the adoption of digital solutions has increased significantly throughout the healthcare industry. This exceptionally strong growth trajectory is expected to continue into the foreseeable future as U.S. healthcare organizations transform to meet the demand for more efficient, clinically integrated and decentralized care systems that serve empowered, technologically-savvy consumers who strongly value convenience and personalization.
  • Billion-dollar Growth Opportunities in the Global Healthcare Industry by 2025 Recorded: Jan 25 2017 59 mins
    Visionary Healthcare Team: Venkat Rajan and Siddharth Shah
    The healthcare industry is undergoing rapid transformation. By 2025, the healthcare ecosystem is expected to look drastically different from today. In 2025, global trends of aging populations, rising chronic disease prevalence and urbanization are bound to further strain healthcare systems already grappling with issues of healthcare access, quality, and cost. In response, new business models are expected to emerge to address the needs of the future. In order to make the most gains, stakeholders must successfully leverage this transformation.
  • Genome Pricing Milestone Warrants New Strategic Positions for Service Providers Recorded: Oct 11 2016 57 mins
    Christi Bird, Senior Industry Analyst, Szilard Voros, Founder and CEO Global Genomics Group
    This briefing will answer the following key questions:
    · How are technology trends, such as new sequencers on the high end (Illumina HiSeq X Ten) and low end (Illumina MiniSeq, Oxford Nanopore MinION), impacting NGS services providers?
    · How will the market change in accordance with the declining cost of sequencing, which hit the $1,000 genome mark?
    · When will the $100 genome be realized, and how will that achievement occur?
    · What are “answer-based services,” and why should NGS service providers be concerned about an impending paradigm shift in the way research questions are answered?
    · How should NGS service providers be positioning now in order to take advantage of the various changes expected in the marketplace over the next 10 years, as well as the growth opportunities available from these changes?
  • Discover Growth Opportunities in the Point-of-care Testing Area Recorded: Sep 7 2016 52 mins
    Divyaa Ravishankar, Paul Pickering, CEO, Ubiquitome, Herbert Torfs, VP Business Development and Strategy, GenePOC
    This briefing reviews recent industry transformations, changes in business models, growth opportunities, and key predictions for the point-of-care testing industry. We will also be joined by Paul Pickering, president and CEO, Ubiquitome, and Herbert Torfs, VP Business Development and Strategy, GenePOC, who will discuss their experience with market trends, regulatory road blocks, and unaddressed needs in the US, Europe, and developing and underdeveloped nations.
  • Moving Beyond APIs - Growth Opportunities in the Pharmaceutical CMO Market Recorded: Aug 16 2016 60 mins
    Frost & Sullivan Transformational Health Team, Chris Chen, CEO, WuXi Biologics, Steve Lam, Senior Vice President, Patheon
    Questions this briefing will address:
    · What are the key challenges the CMOs are likely to face in the near- and long-term future? How can CMOs strategize to overcome these hurdles?
    · What growth opportunities exist in the pharmaceutical contract manufacturing industry?
    · In what ways is the pharmaceutical contract manufacturing industry likely to change to meet industry trends and dynamics?
    · Who are the game-changing companies, and what are the disruptive technologies and business models?
    · How should CMOs strategically position their assets with pharma companies?
  • Disruptive Technologies and Emerging Trends Drive Life Science Transformation Recorded: Jul 7 2016 55 mins
    Transformational Health Team: Nitin Naik, Divyaa Ravishankar, Christi Bird, and Unmesh Lal
    The global pharmaceutical industry is witnessing an unprecedented era. Several new demand spaces such as innovative therapeutics (immuno-oncology), clinical diagnostics (liquid biopsy), and research tools (next-generation sequencing) have emerged, driving companies to sharpen their long-term positions. Fundamental behavioral shifts in these spaces are redefining the market. Companies are adopting a “beyond-the-pill” approach and increasing investments in innovations related to drug discovery, clinical trials, supply-chain solutions, and patient engagement. This briefing reviews recent industry transformations, changes in business models, growth opportunities, and key predictions for the life sciences industry.
  • Leading the New American Hospital: Strategies for Success Recorded: Jun 7 2016 34 mins
    Tanvir Jaikishen and Patrick Riley
    Why You Must Attend:
    • For hospitals to succeed, it is imperative to create a strategy that allows optimal alignment of care provision between providers. There is no “one-size-fits-all approach” to remain competitive.
    •This briefing assesses different strategies adopted by hospitals, which range from smart collaborations with different ambulatory care providers to efficiently manage care transition, adoption of data integration solutions to better create standards of care protocols, and launch of in-house insurance plans to increase patient volumes.
    • An understanding of these strategies is critical for hospitals to create bespoke integrated care delivery solutions that can be used to address local requirements.
    • This briefing also highlights the financial impact of adopting such integrated models of care delivery.
  • Care Delivery Transformation Through Telehealth – Growth Opportunities in APAC Recorded: May 25 2016 51 mins
    Natasha Gulati, Kiranjit Kaur
    Demand for telehealth is on the rise in APAC as healthcare industry stakeholders across the region seek to address challenges of an ageing population and rising healthcare costs. However, market sustainability heavily depends on the establishment of successful business models that provide holistic health and wellness solutions by creating an ecosystem of products and services. In this briefing we will discuss the APAC Telehealth market opportunity with in-depth analysis of technologies, regulations, industry partnerships and business models that will help shape the future of care delivery in the region.
  • Moving Beyond Fitness - Clinical Grade Wearables Poised to Transform Healthcare Recorded: Apr 12 2016 60 mins
    Rhenu Bhuller, Venkat Rajan,Kamaljit Behera - Frost & Sullivan
    Industry convergence and technological innovations are giving rise to a new breed of wearable technologies that are capable of meeting the unique needs and requirements of clinical care settings. Unlike more prevalent general health and fitness devices, these wearables can function with higher levels of accuracy and reliability allowing them to be used by medical professionals to make assessments and recommendations for patients.

    In this interactive briefing, Frost & Sullivan’s Transformational Health team will explore the future applications and opportunities for these innovations, and key strategy considerations for developers.

    Join us as we discuss these and other key topics.
  • 2016 Africa Healthcare Industry Outlook Recorded: Feb 23 2016 57 mins
    Dorman Followwill, Richard Weissenberg, Venkat Rajan
    The healthcare industry is fundamentally influenced by the deployment of technology. More than any other industry, healthcare can benefit from the adoption, and Africa is uniquely positioned to gain from the advances. The audience will receive the following advantages by attending the presentation:

    • Frost & Sullivan will share top predictions for the healthcare industry in Africa for 2016
    • Learn about key trends in the African healthcare industry
    • Uncover areas of opportunity in healthcare
    • Participate in an interactive Q&A session
Frost & Sullivan GIL Webcast Series
Our Healthcare webcasts cover Connected Health, Life Sciences and Advanced Medical Technologies to help you to better understand buyer-seller dynamics as the healthcare system transitions to digital information, the pace at which new and innovative medical devices and systems are being adopted and getting embedded into the typical clinical pathway, both in mature and emerging markets, and enables you to bring clarity to pharmaceutical/biotechnology, in-vitro diagnostics and life science research tools market decisions and implementation tactics.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: OCT: Does It Have What It Takes?
  • Live at: Sep 14 2010 5:00 pm
  • Presented by: Roberto G. Aranibar, Frost & Sullivan Research Analyst
  • From:
Your email has been sent.
or close